We are live on
!
Find out more
GFL
Granite FO LLC Portfolio holdings
AUM
$189M
1-Year Est. Return
56.18%
This Fund
S&P 500
This Quarter
Est. Return
+2.95%
1 Year Est. Return
+56.18%
3 Year Est. Return
+110.9%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$162M
AUM Growth
+$32.3M
(+25%)
Cap. Flow
+$30.2M
Cap. Flow
% of AUM
18.6%
Top 10 Holdings %
Top 10 Hldgs %
65.21%
Holding
246
New
104
Increased
46
Reduced
19
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.97M |
| 2 |
Eli Lilly
LLY
|
+$1.59M |
| 3 |
Apple
AAPL
|
+$1.47M |
| 4 |
SPDR Gold Trust
GLD
|
+$1.05M |
| 5 |
Microsoft
MSFT
|
+$1.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$410K |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$332K |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$326K |
| 4 |
Amazon
AMZN
|
+$259K |
| 5 |
Agnico Eagle Mines
AEM
|
+$236K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.85% |
| 2 | Healthcare | 4.82% |
| 3 | Technology | 3.12% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Staples | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Genmab
GMAB
$17.4B
| – | – |
-2,540
| Closed | -$118K |
|
|
B
227
Barrick Mining
B
$61.2B
| – | – |
-8,730
| Closed | -$142K |
|
228
Idexx Laboratories
IDXX
$45.5B
| – | – |
-169
| Closed | -$72K |
|
229
Ingredion
INGR
$6.34B
| – | – |
-1,515
| Closed | -$148K |
|
230
Jones Lang LaSalle
JLL
$16.6B
| – | – |
-244
| Closed | -$41K |
|
231
KLA
KLAC
$231B
| – | – |
-2,590
| Closed | -$102K |
|
232
Loews
L
$23.8B
| – | – |
-3,915
| Closed | -$228K |
|
233
Medtronic
MDT
$112B
| – | – |
-1,630
| Closed | -$129K |
|
234
Morgan Stanley
MS
$331B
| – | – |
-160
| Closed | -$14.9K |
|
235
Nike
NKE
$63.6B
| – | – |
-640
| Closed | -$70.2K |
|
236
ServiceNow
NOW
$122B
| – | – |
-760
| Closed | -$63.3K |
|
237
O'Reilly Automotive
ORLY
$74.1B
| – | – |
-2,160
| Closed | -$124K |
|
238
Phillips 66
PSX
$82.7B
| – | – |
-125
| Closed | -$13.6K |
|
239
Royalty Pharma
RPRX
$25.5B
| – | – |
-2,401
| Closed | -$106K |
|
|
SCHW
240
Charles Schwab
SCHW
$185B
| – | – |
-1,220
| Closed | -$101K |
|
241
Sherwin-Williams
SHW
$85.5B
| – | – |
-280
| Closed | -$69.8K |
|
242
Travelers Companies
TRV
$78.4B
| – | – |
-825
| Closed | -$157K |
|
243
Tyler Technologies
TYL
$13.2B
| – | – |
-191
| Closed | -$65.5K |
|
244
Visa
V
$693B
| – | – |
-589
| Closed | -$128K |
|
245
Verisk Analytics
VRSK
$25.7B
| – | – |
-609
| Closed | -$112K |
|
|
EQC
246
DELISTED
Equity Commonwealth
EQC
| – | – |
-6,215
| Closed | -$168K |
|
Similar funds
MSFP
HFW
PGDP
WDOM
MAS
PWM
SF
CBT
Granite FO LLC's Q1 2023 Portfolio in Review
As of Q1 2023, Granite FO LLC held 246 positions worth $162M, up 25% from $130M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Granite FO LLC deployed $30.2M of net new capital in Q1 2023, opening 104 new positions and adding to 46 existing holdings. Its largest new stake was Eli Lilly: 4,700 shares worth $1.86M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 29% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $332K trimmed.
- Granite FO LLC's largest Q1 2023 buy was Eli Lilly: 4,700 shares worth $1.86M.
- Granite FO LLC added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $6.97M increase.
- Granite FO LLC's biggest Q1 2023 reduction was Regeneron Pharmaceuticals, cutting an estimated $332K.
- Granite FO LLC fully exited State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2023, selling an estimated $410K.
- Granite FO LLC's ten largest holdings make up 65% of its $162M portfolio in Q1 2023.
- Granite FO LLC opened 104 new positions and closed 33 in Q1 2023.
- Granite FO LLC's portfolio value rose 25% quarter-over-quarter to $162M.
Based on Granite FO LLC's 13F filing for Q1 2023, filed 5 Sep 2024.